Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.56 USD | +0.60% | -10.70% | -29.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.15% | 5.13B | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.33% | 31.99B | |
+50.51% | 24.73B | |
-15.13% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.94% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Wedbush Adjusts Apellis Pharmaceuticals Price Target to $39 From $44, Maintains Neutral Rating